1.226 - 1.250 of 56.827
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 330,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,69x
- Analysis
- Novo Nordisk Call 250,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,26x
- Analysis
- Novo Nordisk Call 340,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,74x
- Analysis
- Novo Nordisk Call 300,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,57x
- Analysis
- Oracle Call 190,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 2,02x
- Analysis
- Novo Nordisk Call 280,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,44x
- Analysis
- Novo Nordisk Call 290,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,49x
- Analysis
- Novo Nordisk Call 270,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,37x
- Analysis
- Novo Nordisk Call 330,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,84x
- Analysis
- Novo Nordisk Call 240,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,17x
- Analysis
- Novo Nordisk Call 400,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,22x
- Analysis
- Novo Nordisk Call 370,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,10x
- Analysis
- Novo Nordisk Call 350,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,97x
- Analysis
- Novo Nordisk Call 300,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,66x
- Analysis
- Moderna Call 29,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 1,91x
- Analysis
- Novo Nordisk Call 380,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,15x
- Analysis
- Moderna Call 31,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 1,97x
- Analysis
- Novo Nordisk Call 320,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,81x
- Analysis
- Moderna Call 27,00 17 Jun 2027
- Goldman Sachs
- 17.06.27
- 1,78x
- Analysis
- Novo Nordisk Call 290,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,60x
- Analysis
- Novo Nordisk Call 280,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,56x
- Analysis
- Novo Nordisk Call 360,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,82x
- Analysis
- Novo Nordisk Call 360,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 3,01x
- Analysis
- Novo Nordisk Call 310,00 17 Sep 2027
- Goldman Sachs
- 17.09.27
- 2,73x
- Analysis
- Novo Nordisk Call 320,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,62x
- Analysis